Vanqua Bio logo

Vanqua Bio

Chicago, IL

Vanqua Bio is helping usher in a new era of hope for the millions of people living with neurodegenerative diseases. Our unique drug-development approach is designed to overcome longstanding challenges in the neuroscience field by capitalizing on the power of human genetics to identify genes that cause or increase the risk of neurodegenerative disease. We leverage novel, proprietary research tools and in vitro modeling of disease, based on patient-derived neuronal cells, to develop transformative therapies that slow or stop the progression of Parkinson’s disease (PD), Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and Gaucher disease (GD).

vanquabio.com

Company Details

Founded

2019

Employees

Between 20 - 50 employees

Raised

$129,979,984

Headquarters Location

Chicago, IL

Public

No

Acquired

No

CEO

Jim SullivanJim Sullivan

Founders

Jim Sullivan
Jim Sullivan

Company Collections

These are collections Vanqua Bio is a part of. Click on the collection name to view similar companies.

Vanqua Bio Headquarters Location

2430 N. Halstad St. Ste. 110, Chicago, IL 60614

Total Amount Raised: $129,979,984

Vanqua Bio Funding Rounds

  • Series Unknown

    $44,979,987

  • Series B

    $85,000,000

    Series B Investors

    Omega Fund Management
    Surveyor Capital
    Eli Lilly and Company
    Avoro Ventures
    OrbiMed Advisors
    OUP (Osage University Partners)
    Pontifax
    Casdin Capital
    Logos Capital
Funding info provided by Diffbot.

Vanqua Bio Reviews

0 out of 5 stars

Based on 0 reviews

Review data

Share your thoughts

Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Vanqua Bio.

Recent reviews